Trademark: 90818273
Status Date
Tuesday, February 20, 2024
Filing Date
Thursday, July 8, 2021
Abandoned Date
Tuesday, February 20, 2024
9 Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling
5 Assay kits comprising clinical medical reagents for culturing cells for clinical medical use
1 Assays for clinical or laboratory research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents for culturing cells for clinical laboratory or research use
44 Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies
10 Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies
42 Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology
THREE DIMENSIONAL PREDICT OVARIAN
Feb 20, 2024
Abandonment Notice Mailed - After Ex Parte Appeal
Feb 20, 2024
Abandonment - After Ex Parte Appeal
Feb 20, 2024
Exparte Appeal Terminated
Jan 10, 2024
Exparte Appeal Dismissed - Failure To File Brief
Oct 18, 2023
Notification Of Action Denying Req For Recon E-Mailed
Oct 18, 2023
Action Denying Req For Recon E-Mailed
Oct 18, 2023
Action Continuing Final - Completed
Aug 18, 2023
Teas/Email Correspondence Entered
Aug 18, 2023
Correspondence Received In Law Office
Apr 27, 2023
Teas Request For Reconsideration Received
Apr 27, 2023
Ex Parte Appeal-Instituted
Apr 27, 2023
Jurisdiction Restored To Examining Attorney
Apr 27, 2023
Exparte Appeal Received At Ttab
Oct 27, 2022
Notification Of Final Refusal Emailed
Oct 27, 2022
Final Refusal E-Mailed
Oct 27, 2022
Final Refusal Written
Sep 30, 2022
Teas/Email Correspondence Entered
Sep 29, 2022
Correspondence Received In Law Office
Sep 29, 2022
Teas Response To Office Action Received
Mar 30, 2022
Notification Of Non-Final Action E-Mailed
Mar 30, 2022
Non-Final Action E-Mailed
Mar 30, 2022
Non-Final Action Written
Mar 28, 2022
Assigned To Examiner
Sep 16, 2021
New Application Office Supplied Data Entered
Jul 12, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
